All Stories

  1. Handwriting patterns in isolated rapid eye movement sleep behaviour disorder
  2. Strength of associations between regional brain volumes and dual decline in gait and memory
  3. A comprehensive review on deep supervision in computer vision
  4. Circadian dysregulation in probable isolated REM sleep behaviour disorder: actigraphy insights from the Tasmanian ISLAND Sleep Study
  5. Remote unsupervised tests of isolated REM sleep behaviour disorder in the community: results from the Tasmanian ISLAND Sleep Study
  6. Large-scale Visuomotor Reaction Time Self-Testing Reveals Subtle Motor Changes in Older Adults with Subjective Cognitive Impairment
  7. Tongue strength and cognitive decline in older adults: A scoping review
  8. Smartphone self-testing of hand and speech motor functions: a study of reliability and usability in older adults
  9. Parallel Multi-Scale Deep Supervision Net for Hand Key Point Detection
  10. Associations Between Regional Brain Volumes and Dual Decline in Gait Speed and Memory
  11. Evaluating the Impact on Clinician Diagnostic Confidence and Management Following Disclosure of Alzheimer's Disease Probability Informed by Plasma pTau181 Levels in Memory and Cognition Clinic Patients: A Before‐and‐After Study
  12. Investigating the contribution of tongue strength measurement in determining pre‐clinical Alzheimer's disease pathology in older adults
  13. New insights from combining gait and hand motor function in classification of amnestic MCI and Alzheimer's Disease
  14. Physical activity and blood‐based biomarkers of neurodegeneration in community dwelling Australians from ISLAND (Island Study Linking Ageing and Neurodegenerative Disease)
  15. A word in the hand is worth two in the push: Comparing vocal and manual responses to the arrow-word Stroop task
  16. Association of tongue, handgrip, and pinch strength with blood-based phosphorylated-tau 181 in cognitively healthy older adults
  17. Modifiable Dementia Risk Factors by Country of Birth among South Asian Migrants Aged 50 or Older in Tasmania, Australia
  18. Association of chronic pain and analgesic use with the risks of Parkinson’s and Alzheimer’s disease
  19. The Tasmania-London protocol to detect isolated rapid eye movement sleep behavior disorder using home-based video-polysomnography
  20. Advice to people with Parkinson's in my clinic: How to manage running-induced dystonia
  21. Gait in Older People with Cognitive Impairments During Rhythmic Auditory Cueing: A Scoping Review
  22. Chronic Pain in Parkinson’s Disease: Prevalence, Sex Differences, Regional Anatomy and Comorbidities
  23. Are We Asking the Right Questions? Sex Specificity of Dream Characteristics in Probable Rapid Eye Movement Sleep Behavior Disorder
  24. Evaluating the impact of human expertise in human-centered AI: A case study on finger-tapping video analysis for dementia detection
  25. Falls in people with Alzheimer’s disease: Exploring the role of inhibitory control
  26. Digitised hand movement and plasma NfL are complementary biomarkers of the dementia continuum
  27. Modifiable dementia risk factors by country of birth among South Asian migrants aged 50 or older in Tasmania, Australia
  28. A comparison of modifiable risk factors for dementia among South Asian migrants and non-migrants aged 50 or older in Tasmania, Australia
  29. Physical activity and blood‐based biomarkers of neurodegeneration in community dwelling Australians from ISLAND (Island Study Linking Ageing and Neurodegenerative Disease)
  30. Self-testing for symptoms and signs of prodromal alpha-synucleinopathies: results from the Tasmanian ISLAND Sleep Study
  31. Putting the patient first: Should general practitioners start people with probable Parkinson’s disease on levodopa while awaiting diagnostic confirmation?
  32. Rapid repetitive syllable sounds associate with episodic memory, executive function, and working memory in cognitively healthy and subjectively impaired older adults
  33. Presymptomatic blood tests to detect neurodegeneration: Perceptions of potential consumers across the life course
  34. The Tasmania-London (TASLON) 3-step home-based video-polysomnography approach to detect iRBD in the community: protocol and preliminary results
  35. Impact of Plasma pTau181 Levels on Clinician Diagnostic Confidence and Management in Memory and Cognition Clinics: A Multi-site Before-and-After Study
  36. Stepping and tapping: combining motor tasks improves cognitive classification
  37. Keeping an eye on Parkinson’s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers
  38. Deep Learning Analysis of Figure Copying Tasks for Parkinson’s Disease Detection with GAN-Based Data Augmentation
  39. Post-diagnostic support in Australia: Perspectives of people recently diagnosed with dementia and their carers
  40. Handwriting patterns in Isolated Rapid Eye Movement Sleep Behaviour Disorder
  41. Mild Cognitive Impairment: Far from “Mild,” but Is Deep Brain Stimulation the Solution?
  42. Computer Vision in Clinical Neurology
  43. Feasibility of computerized motor, cognitive and speech tests in the home: Analysis of TAS Test in 2,300 older adults
  44. Falls in people with Alzheimer’s Disease: Exploring the role of inhibitory control
  45. Chronic Pain in Parkinson’s Disease: Prevalence, Sex Differences, Regional Anatomy and Comorbidities
  46. Development of a diagnostic checklist to identify functional cognitive disorder versus other neurocognitive disorders
  47. Developing, implementing, and evaluating the first national Memory and Cognition Clinic Guidelines in Australia
  48. ISLAND Campus: a fee-free formal university educational intervention in mid- to later-life to reduce modifiable risk factors for dementia and improve cognition
  49. Associations Between Brain Structure and Dual Decline in Gait and Cognition
  50. Immediate post‐diagnostic support for people with dementia and thier care partners: Scoping literature review
  51. Impact of free later life formal university education on longitudinal modifiable risk factors, cognition and plasma phosphorylated tau 181
  52. Rural‐urban improvements in modifiable risk factors across Tasmania from an online, public health dementia risk reduction initiative: data from ISLAND (Island Study Linking Ageing and Neurodegenerative Disease)
  53. Tapping into a new hand‐motor biomarker of the dementia continuum ‐ integration and validation in a cognitive clinic
  54. Unsupervised online reaction time test improves estimation of cognitive function in a large sample of cognitively‐asymptomatic older adults
  55. Using TAS Test online hand‐tapping tests to detect cognitive decline in a large community cohort of older Australians
  56. Chronic Musculoskeletal Pain and Risk of Incident Parkinson's Disease: A 13‐Year Longitudinal Study
  57. Validation of computer vision technology for analyzing bradykinesia in outpatient clinic videos of people with Parkinson's disease
  58. Associations between brain structure and dual decline in gait and cognition
  59. P027 Dream characteristics are sex-specific in REM Sleep Behaviour Disorder and healthy older adults
  60. Smartphone automated motor and speech analysis for early detection of Alzheimer's disease and Parkinson's disease: Validation of TapTalk across 20 different devices
  61. Practical Ultrasound
  62. Deep learning of Parkinson's movement from video, without human-defined measures
  63. Hand Motor Dysfunction Is Associated with Both Subjective and Objective Cognitive Impairment across the Dementia Continuum
  64. Validation and application of computer vision algorithms for video-based tremor analysis
  65. The Parkinson's Puzzle Box
  66. Widening the Phenotype of Fragile‐X Tremor Ataxia Syndrome in Females: Spasmodic Dysphonia in Two Patients
  67. Perspectives on the diagnosis and management of functional cognitive disorder: An international Delphi study
  68. Identifying and Managing Drug Induced Parkinsonism: The Role of Neuroscience Nurses
  69. Development of a smartphone screening test for preclinical Alzheimer’s disease and validation across the dementia continuum
  70. Modifiable dementia risk factors and AT(N) biomarkers: findings from the EPAD cohort
  71. Transdermal Rotigotine at End-of-Life for Parkinson's Disease: Association With Measures of Distress
  72. The effect of dyskinesia on postural control, balance, gait, and fall risk in people with Parkinson’s disease: a systematic review protocol
  73. Brief webcam test of hand movements predicts episodic memory, executive function, and working memory in a community sample of cognitively asymptomatic older adults
  74. Parallel scale de-blur net for sharpening video images for remote clinical assessment of hand movements
  75. Rapid-Motion-Track: Markerless tracking of fast human motion with deep learning
  76. Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum
  77. Visual perceptive deep learning for smartphone video-based tremor analysis: VIPER-Tremor
  78. Clinical validation of TAS Test automated hand motor analysis to discriminate subjective cognitive decline, mild cognitive impairment and dementia in a multidisciplinary cognitive clinic
  79. Clinical validation of TAS Test automated hand motor analysis to discriminate subjective cognitive decline, mild cognitive impairment and dementia in a multidisciplinary cognitive clinic
  80. Identifying preclinical Alzheimer’s disease in the community with brief automated hand movement analysis: validation against plasma ptau181 and asymptomatic episodic memory decline
  81. Identifying preclinical Alzheimer’s disease in the community with brief automated hand movement analysis: validation against plasma ptau181 and asymptomatic episodic memory decline
  82. Isolated REM sleep behaviour disorder in the Tasmanian ISLAND Sleep Study: prevalence and profiles of prodromal dementia
  83. Modifiable dementia risk factor associations with AT(N) biomarkers: Findings from the European Prevention of Alzheimer’s Dementia study
  84. Plasma phosphorylated tau 181 and modifiable risk factors for dementia in a large scale cohort of Australian older adults
  85. Tasmanian ISLAND Sleep Study: prodromal neurodegenerative disease (iRBD) is associated with subjective reports of daytime sleepiness and poor sleep quality
  86. Isolated rapid eye movement sleep behaviour disorder (iRBD) in the Island Study Linking Ageing and Neurodegenerative Disease (ISLAND) Sleep Study: protocol and baseline characteristics
  87. Enhancing post-diagnostic care in Australian memory clinics: Health professionals’ insights into current practices, barriers and facilitators, and desirable support
  88. Brain Networks Involved in Sensory Perception in Parkinson’s Disease: A Scoping Review
  89. Modifiable risk factors for dementia, cognition, and plasma phosphorylated tau 181 in a large-scale cohort of Australian older adults
  90. Current evidence on the association of tongue strength with cognitive decline in older adults and the known risk factors of frailty, sarcopenia and nutritional health: a scoping review protocol
  91. An online, public health framework supporting behaviour change to reduce dementia risk: interim results from the ISLAND study linking ageing and neurodegenerative disease
  92. Pushing through the Barriers: Peer Advice to Increase Physical Activity and Reduce Dementia Risk from Participants in a Massive Open Online Alzheimer's Focused Course
  93. Does serum neurofilament light help predict accelerated cognitive ageing in unimpaired older adults?
  94. 15 TAS test clinical validation: automated hand movement analysis helps discriminate subjective cognitive decline, mild cognitive impairment and dementia
  95. 2692 The future is in our hands: screening for preclinical alzheimer’s disease at home using automated analysis of hand movements
  96. A new one‐stop interdisciplinary cognitive clinic model tackles rural health inequality and halves the time to diagnosis: Benchmarked against a national dementia registry
  97. Estimating presymptomatic episodic memory impairment using simple hand movement tests: A cross‐sectional study of a large sample of older adults
  98. Contactless hand tremor amplitude measurement using smartphones: development and pilot evaluation
  99. Multimodal learning of clinically accessible tests to aid diagnosis of neurodegenerative disorders: a scoping review
  100. Investigating the associations between upper limb motor function and cognitive impairment: a scoping review
  101. Parkinsonian Hand or Clinician’s Eye? Finger Tap Bradykinesia Interrater Reliability for 21 Movement Disorder Experts
  102. Instruments measuring change in cognitive function in multiple sclerosis: A systematic review
  103. Functional neurological disorder is a feminist issue
  104. An online, public health framework supporting behaviour change to reduce dementia risk: interim results from the Island Study Linking Ageing and Neurodegenerative Disease
  105. Sex-Specific Protective Effects of Cognitive Reserve on Age-Related Cognitive Decline
  106. Clinicians' implicit and explicit attitudes about the legitimacy of functional neurological disorders correlate with referral decisions
  107. Of Mice and Pose: 2D Mouse Pose Estimation from Unlabelled Data and Synthetic Prior
  108. REM sleep behaviour disorder: the importance of early identification in primary care
  109. Real-time automated detection of older adults' hand gestures in home and clinical settings
  110. Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease
  111. Differences in clinical manifestations of late-onset, compared to earlier-onset essential tremor: A scoping review
  112. Moving towards intelligent telemedicine: Computer vision measurement of human movement
  113. The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer’s disease and estimate 5-year risks of cognitive decline and dementia
  114. Systemic lupus erythematosus-induced intracranial hypertension: rare but important
  115. Challenges of Incorporating Digital Health Technology Outcomes in a Clinical Trial: Experiences from PD STAT
  116. Geste Antagoniste Effects on Motor Performance in Dystonia—A Kinematic Study
  117. Diagnostic Accuracy of the Overlapping Infinity Loops, Wire Cube, and Clock Drawing Tests in Subjective Cognitive Decline, Mild Cognitive Impairment and Dementia
  118. New horizons in late-onset essential tremor: a pre-cognitive biomarker of dementia?
  119. Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies
  120. To the emergency room and back again: Circular healthcare pathways for acute functional neurological disorders
  121. 248  Tremor frequency can be measured using smartphone video
  122. Increased Knowledge of Adult-Onset Dystonia Amongst Medical Students via Brief Video Education: A Systematic Review and Cohort Study
  123. Island Study Linking Aging and Neurodegenerative Disease (ISLAND) Targeting Dementia Risk Reduction: Protocol for a Prospective Web-Based Cohort Study
  124. Applications of artificial intelligence to aid early detection of dementia: A scoping review on current capabilities and future directions
  125. Truth, hope and the disclosure of a dementia diagnosis: A scoping review of the ethical considerations from the perspective of the person, carer and clinician
  126. Are tomorrow’s doctors prepared to prevent dementia? A cross-sectional study of Tasmanian medical students’ knowledge of dementia risk factors
  127. Evolutionary Design of Reduced Precision Levodopa-Induced Dyskinesia Classifiers
  128. Automated analysis of propositional idea density in older adults
  129. TasTest: Moving towards a digital screening test for pre‐clinical Alzheimer’s disease
  130. Island Study Linking Aging and Neurodegenerative Disease (ISLAND) Targeting Dementia Risk Reduction: Protocol for a Prospective Web-Based Cohort Study (Preprint)
  131. Parkinson’s disease diagnosis using convolutional neural networks and figure-copying tasks
  132. Association Between Components of Cognitive Reserve and Serum BDNF in Healthy Older Adults
  133. Hand tremor detection in videos with cluttered background using neural network based approaches
  134. Significant cognitive decline in Parkinson's disease exacerbates the reliance on visual feedback during upper limb reaches
  135. Significant cognitive decline in Parkinson’s disease exacerbates the reliance on visual feedback during upper limb reaches
  136. Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit
  137. An Innovative Personalised Management Program for Older Adults with Parkinson’s Disease: New Concepts and Future Directions
  138. Moving Towards Intelligent Telemedicine: Computer Vision Measurement of Human Movement
  139. Studying at university in later life slows cognitive decline: A long‐term prospective study
  140. Accuracy of Smartphone Video for Contactless Measurement of Hand Tremor Frequency
  141. The Island Study Linking Ageing and Neurodegenerative Disease (ISLAND): A longitudinal public health research program targeting dementia risk reduction
  142. Seeing the unseen: Could Eulerian video magnification aid clinician detection of subclinical Parkinson’s tremor?
  143. Supervised classification of bradykinesia in Parkinson’s disease from smartphone videos
  144. What is it like to live with a functional movement disorder? An interpretative phenomenological analysis of illness experiences from symptom onset to post‐diagnosis
  145. The discerning eye of computer vision: Can it measure Parkinson's finger tap bradykinesia?
  146. Get Parkinson’s medications on time: the Leeds QI project
  147. Time series clustering to examine presence of decrement in Parkinson’s finger-tapping bradykinesia
  148. Oromandibular dystonia: a diagnosis not to miss
  149. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controll...
  150. Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
  151. Can we reduce the risk of dementia with exercise?
  152. 127 Audit of poor response to botulinum toxin in cervical dystonia
  153. Health at the writing desk of John Ruskin: a study of handwriting and illness
  154. Application of classification for figure copying test in Parkinson's disease diagnosis by using cartesian genetic programming
  155. Multiple myeloma with multiple neurological presentations
  156. Computer vision of smartphone video has potential to detect functional tremor
  157. Supervised Classification of Bradykinesia for Parkinson's Disease Diagnosis from Smartphone Videos
  158. Multiple system atrophy mimicked by multi-organ pathology
  159. Inferring the long duration response to levodopa in Parkinson’s disease
  160. FM2-1 A smartphone camera can detect functional tremor
  161. P68 Activation of the geste antagoniste improves speed of finger tapping in organic and functional dystonia
  162. P66 Should we be screening for depression and quality of life in all patients attending botulinum toxin injection clinics or just those with cervical dystonia?
  163. A smartphone camera reveals an ‘invisible’ Parkinsonian tremor: a potential pre-motor biomarker?
  164. WED 109 Computer vision: a smartphone camera can ‘see’ bradykinesia
  165. 292 Mapping patient pathways for acute functional neurological symptoms
  166. WED 112 Seeing invisible parkinsonian tremor with a smartphone camera
  167. Objective assessment of bradykinesia in Parkinson’s disease using evolutionary algorithms: clinical validation
  168. 131A quality improvement project to improve the care of people with Parkinson’s in a large teaching hospitals trust
  169. Cognitive deficits in Parkinson’s disease: current perspectives
  170. Objective Evaluation of Bradykinesia in Parkinson’s Disease using Evolutionary Algorithms
  171. A New Evolutionary Algorithm-Based Home Monitoring Device for Parkinson’s Dyskinesia
  172. How to use pen and paper tasks to aid tremor diagnosis in the clinic
  173. A History of Dystonia: Ancient to Modern
  174. Lesson of the month 1: Subacute thyroiditis: a rare cause of fever of unknown origin
  175. Lesson of the month 2: Transient reversible amnesia in multiple sclerosis
  176. Going through directional changes
  177. Objective Assessment of Cognitive Impairment in Parkinson’s Disease Using Evolutionary Algorithm
  178. Exploring diagnostic models of Parkinson's disease with multi-objective regression
  179. Functional dystonia and the borderland between neurology and psychiatry: New concepts
  180. Dystonia in a prolific medieval scribe
  181. Using epigenetic networks for the analysis of movement associated with levodopa therapy for Parkinson's disease
  182. Study of levodopa response in Parkinson's disease: Observations on rates of motor progression
  183. A Multi-Objective Approach to Predicting Motor and Cognitive Deficit in Parkinson's Disease Patients
  184. Using Multiobjective Evolutionary Algorithms to Understand Parkinson's Disease
  185. What to do when people with Parkinson's disease cannot take their usual oral medications
  186. Computational approaches for understanding the diagnosis and treatment of Parkinson's disease
  187. Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?
  188. Cost Effectiveness Analysis of A Device to Monitor Levodopa-Induced Dyskinesia In Parkinson’s Patients
  189. Reply: Essential tremor in ‘The tremulous hand of Worcester’: additional comments
  190. FINGER TAPPING AND COGNITION IN PARKINSON'S
  191. THE RELATIONSHIP BETWEEN CLOCK DRAWING AND COGNITION IN PARKINSON'S
  192. VISUOSPATIAL TESTS TO SCREEN FOR IMPAIRED COGNITION IN PARKINSON'S
  193. What type of tremor did the medieval ‘Tremulous Hand of Worcester’ have?
  194. When myopathy breaks the rules: a late-onset distal presentation
  195. Cognitive impairment in Parkinson's disease
  196. Evolving Classifiers to Recognize the Movement Characteristics of Parkinson's Disease Patients
  197. Classification and characterisation of movement patterns during levodopa therapy for parkinson's disease
  198. Clinically ‘/INS;slight’/INS; bradykinesia is accurately detected using a novel device that requires a one-minute test period
  199. The sequence effect is not a defining characteristic of Parkinson'/INS;s disease
  200. Practical Ultrasound
  201. Palliative care for Parkinson’s disease: A summary of the evidence and future directions
  202. Characterisation of movement disorder in parkinson's disease using evolutionary algorithms
  203. Characterising neurological time series data using biologically motivated networks of coupled discrete maps
  204. Evolving classifiers to inform clinical assessment of Parkinson's disease
  205. Longitudinal study of levodopa in Parkinson's disease: Effects of the advanced disease phase
  206. 103 Computer assisted diagnosis and monitoring of Parkinson's disease
  207. Evolving Computational Dynamical Systems to Recognise Abnormal Human Motor Function
  208. PO.11 How is stroke thrombolysis affecting neurology training?
  209. A practical guide to the differential diagnosis of tremor
  210. A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease
  211. Longitudinal study of the levodopa motor response in Parkinson's disease: Relationship between cognitive decline and motor function
  212. John Ruskin's relapsing encephalopathy
  213. Multi-system complications of hypothermia: a case of recurrent episodic hypothermia with a review of the pathophysiology of hypothermia
  214. Cluster-like headache secondary to trigeminal meningioma
  215. A patient with neuro-Behçet's disease is successfully treated with etanercept: Further evidence for the value of TNFα blockade
  216. Pulmonary artery dissection: an emerging cardiovascular complication in surviving patients with chronic pulmonary hypertension
  217. Editorial
  218. The well-tempered computer
  219. Dorians and Ionians